Job Description

This position resides within our company\'s Center for Observational and Real-World Evidence (CORE), which leads value evidence strategy development and conducts research to inform healthcare decision making.

Under the guidance of a senior leader, the Senior Director for Precision Medicine and Innovative Strategies has the primary responsibility for developing and executing the strategy to help define the unmet needs and demonstrate the value and affordability of precision medicine including oncology biomarkers and diagnostics and other emerging tools and platforms. Additional responsibility includes supporting the clinical development team that is focused on innovative therapeutic approaches such as tumor agnostic programs and in addressing the needs of underserved patient populations. This position would have people management responsibility.

The incumbent in this role will develop close connections across several functions to gain insights and feedback on opportunities to leverage real-world evidence to support product development, demonstrate the value of emerging biomarkers and diagnostic platforms and advance our precision medicine vision. Key internal stakeholders include tumor-specific Value Evidence Sub-teams, Global and US commercial, Global Market Access and Global Medical and Scientific affairs. The incumbent is expected to keep abreast of the latest advances and developments in oncology biomarkers and diagnostic platforms as they relate to real-world data and evidence generation, strategic partnerships, and opportunities to shape the broader diagnostic ecosystem. The incumbent would harness quantitative research and health economics skills, experience in real world studies, and understanding of the rapidly evolving paradigm of precision medicine.

The incumbent will:

Lead strategic and technical discussions in the cross functional Precision Medicine Value Team (PMVT) and the Innovative Strategies Value Team for stakeholder input, alignment and/or awareness on key topic and subject matter

Collaborate with stakeholders within tumor specific and pan tumor Value Teams (VT) and Value and Implementation (V&I) teams as well as cross functionally including global medical affairs, policy, global and US commercial to understand the value evidence needs for the diagnostics and biomarkers so as to enable the optimal use of our medicines in biomarker-/diagnostic-based indications

Represent CORE on one or more VTs and provide leadership in developing the value evidence strategies and plans for developmental biomarkers and diagnostic assays identified by cross-functional stakeholders

Critically assess drivers and barriers to reimbursement and successful implement of diagnostic testing in routine care and identifies value evidence needs to provide strategic input into clinical, diagnostic and market development programs.

Brings strong payer and HTA/reimbursement focus into the Diagnostic Development Team(s) and has expertise in demonstrating the clinical and economic value of the diagnostic assays to payers

Develop the integrated evidence strategy to address the barriers identified for one or more biomarker-based indications

Stay abreast of emerging methodological approaches in the economic/HTA evaluation of biomarkers and diagnostics

Lead precision medicine evidence generation studies from concept development through publication in peer-reviewed journals with appropriate guidance

Effectively communicate findings from research activities throughout our Company and external stakeholders at leading scientific meetings

Build relationships with precision medicine health economic and outcomes research leaders worldwide

Education Minimum Requirement:

Doctoral degree from a recognized school in medicine, public health, health services research, decision sciences, pharmacy, or related field

Required Experience and Skills:

In-depth understanding of oncology real-world data sources and real-world evidence generation to generate scientifically rigorous value evidence from secondary data sources

7+ years post PhD degree of relevant experience in epidemiology or outcomes research as applied to biomarkers, diagnostics or digital technologies

Demonstrated expertise in the design and implementation of clinical, epidemiological, or health economic studies relevant to biomarkers and diagnostic assays

Demonstrated expertise in the fields of outcomes research, health services research, epidemiology or health economics, and/or health technology assessment

A track record of scientific presentations and publications

Strong leadership and strategic thinking skills

Effective oral and written communication skills that enables impact with key stakeholders

Demonstrated ability in developing competencies in new topics or methods

Preferred Experience and Skills:

Experience in precision oncology-related outcomes research, epidemiology or health economics preferred.

NOTICE FOR INTERNAL APPLICANTS

In accordance with all employees subject to this policy are required to have a minimum of twelve (12) months of service in current position prior to applying for open positions.

If you have been offered a separation benefits package, but have not yet reached your separation date and are offered a position within the salary and geographical parameters as set forth in the Summary Plan Description (SPD) of your separation package, then you are no longer eligible for your separation benefits package. To discuss in more detail, please contact your HRBP or Talent Acquisition Advisor.

Employees working in roles that the Company determines require routine collaboration with external stakeholders, such as customer-facing commercial, or research-based roles, will be expected to comply not only with Company policy but also with policies established by such external stakeholders (for example, a requirement to be vaccinated against COVID-19 in order to access a facility or meet with stakeholders). Please understand that, as permitted by applicable law, if you have not been vaccinated against COVID-19 and an essential function of your job is to call on external stakeholders who require vaccination to enter their premises or engage in face-to-face meetings, then your employment may pose an undue burden to business operations, in which case you may not be offered employment, or your employment could be terminated. Please also note that, where permitted by applicable law, the Company reserves the right to require COVID-19 vaccinations for positions, such as in Global Employee Health, where the Company determines in its discretion that the nature of the role presents an increased risk of disease transmission.

Current Employees apply

Current Contingent Workers apply

US and Puerto Rico Residents Only:

Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please if you need an accommodation during the application or hiring process.

We are an Equal Opportunity Employer, committed to fostering an inclusive and diverse workplace. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or other applicable legally protected characteristics. For more information about personal rights under the U.S. Equal Opportunity Employment laws, visit:

We are proud to be a company that embraces the value of bringing diverse, talented, and committed people together. The fastest way to breakthrough innovation is when diverse ideas come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another\xe2\x80\x99s thinking and approach problems collectively.

U.S. Hybrid Work Model

Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, generally Tuesday, Wednesday and either Monday or Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence. This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by a collective-bargaining agreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as \xe2\x80\x9cremote\xe2\x80\x9d.

Under New York City, Colorado State, Washington State, and California State law, the Company is required to provide a reasonable estimate of the salary range for this job. Final determinations with respect to salary will take into account a number of factors, which may include, but not be limited to the primary work location and the chosen candidate\xe2\x80\x99s relevant skills, experience, and education.

Expected salary range: $193,440.00 - $304,500.00

Available benefits include bonus eligibility, health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and sick days. For Washington State Jobs, a summary of benefits is listed .

Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.

Employee Status: Regular

Relocation: Domestic

VISA Sponsorship: No

Travel Requirements: 10%

Flexible Work Arrangements: Hybrid

Shift: Not Indicated

Valid Driving License: Yes

Hazardous Material(s): n/a

Merck & Co.